1. Durham, N.C.-based medical technology company Bioventus acquired rehabilitation solutions company Bioness for $45 million upfront consideration, with up to $65 million contingent consideration.
2. Spinal implant manufacturer SeaSpine on April 1 added Shweta Singh Maniar to its board of directors.
3. SeaSpine shared its preliminary financial report for the first quarter.
4. The 9th U.S. Circuit Court of Appeals revived a lawsuit April 2 accusing Medtronic of violating the False Claims Act by misrepresenting select spine devices to the FDA for clearance.
5. The FDA approved NuVasive’s Simplify cervical artificial disc for two-level total disc replacement.
6. Ron Matricaria, chair of the Orthofix board of directors since 2014, will not seek reelection at the company’s 2021 annual meeting.
More articles on devices:
Which spine procedures are surgeons migrating to the ASC in 2021?
The next 3 years in spine: What will gain ground on fusion?
5 ways spine surgery is changing: ASCs, endoscopic surgery & more
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.